| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| SpringWorks Therapeutics, Inc. | Director, 10%+ Owner | Common Stock | 6,186,307 | $256,917,330 | $41.53 | 19 May 2022 | Indirect |
| SpringWorks Therapeutics, Inc. | Director, 10%+ Owner | Common Stock | 131,652 | $5,467,508 | $41.53 | 19 May 2022 | Direct |
| Compass Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 30,000 | 18 Feb 2022 | Direct | ||
| SpringWorks Therapeutics, Inc. | Director, 10%+ Owner | Stock Option (Right to Buy) | 15,318 | 19 May 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SWTX | SpringWorks Therapeutics, Inc. | 19 May 2022 | 2 | $0 | 4 | Director, 10%+ Owner | 20 May 2022, 17:44 |
| CMPX | Compass Therapeutics, Inc. | 18 Feb 2022 | 1 | $0 | 4 | Director | 23 Feb 2022, 16:45 |
| SWTX | SpringWorks Therapeutics, Inc. | 20 May 2021 | 2 | $0 | 4 | Director, 10%+ Owner | 21 May 2021, 16:31 |